ArticleMolecular cancer therapeutics2025

Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.

Maryam Labaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.